trending Market Intelligence /marketintelligence/en/news-insights/trending/uiLpJN7d-vWoPLaad0hOXw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Report: Activist investor mulls take-private offer for Medifast

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Report: Activist investor mulls take-private offer for Medifast

Hedge fund Engaged Capital LLC is considering a take-private offer for Medifast Inc., Bloomberg News reported, citing people familiar with the matter.

Sources reportedly said the California-based activist investor, which owns 15% of the supplement company, has been in talks with banks and private equity firms to help finance a bid. Engaged Capital disclosed its stake in Medifast in November, saying the company was undervalued.

No decision has been finalized yet and Engaged Capital may not proceed with an offer, the sources reportedly added.

A representative for Engaged declined to comment, Bloomberg News reported. Meanwhile, a Medifast representative could not be reached for comment.

Shares of Medifast close up 1.6% at $105 on Dec. 23.